Cite
HARVARD Citation
Atsukawa, M. et al. (2019). Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan. Hepatology research. 49 (4), pp. 369-376. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Atsukawa, M. et al. (2019). Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan. Hepatology research. 49 (4), pp. 369-376. [Online].